| | Key Words | | Study Title
| | Status
|
| | AMD3100, Peripheral Blood Stem Cells, Transplantation, RP124 | | Compassionate Use Protocol for the Use of AMD3100 to Mobilize Peripheral Blood Stem Cells for Collection and Transplantation | | Open to Entrollment |
| | Pediatric Leukemia, Myelodysplasia, Umbilical Cord Blood (UCB Transplantation, RP127 | | Multi-center, Open Label, Randomized Trial Comparing Single versus Double Umbilical Cord Blood (UCB) Transplantation in Pediatric Patients with Leukemia and Myelodysplasia | | Open to Enrollment |
| | Marrow Transplantation, HLA-Matched Family Members, Severe Aplastic Anemia, RP128 | | Cyclophosphamide and Antithymocyte Globulin Conditioning Regimen for Marrow Transplantation from HLA-Matched Family Members for Severe Aplastic Anemia: Effect of Marrow Cell Dose on Chronic Graft-vs.-Host Disease: A Multi-Center Trial | | Open to Enrollment |
| | Allogeneic Stem Cell Transplantation, Myelofibrosis, RP129 | | Study of Fludarabine Based Conditioning for Allogeneic Stem Cell Transplantation for Myelofibrosis | | Open to Enrollment |
| | Randomized Trial, Prophylaxis, Hematopoietic StemCell Transplantation, Relapsed ALL, RP130 | | A Randomized Trial of Sirolimus-Based Graft versus Host Disease Prophylaxis after Hematopoietic Stem Cell Transplantation in Relapsed ALL | | Open to Enrollment |
| | Unrelated bone marrow transplant, unrelated stem cell transplant, allogenetic transplant | | Development of a National Marrow Donor Program Research Database for Unrelated Stem Cell Transplantion | | Open to Enrollment |
| | Unrelated bone marrow transplant, unrelated stem cell transplant, allogenetic transplant | | NMDP Research Sample Depository for Unrelated Stemm Cell Transplantation Research | | Open to Enrollment |
| | Stem cell transplantation, bone marrow donation | | Study of G-CSF-moblized pheriperal sblood stem cells versus marrow collection for transplantation | | Open to Enrollment |
| | Unrelated matched siblings, patients with hematologic malignancies, GVHD, unrelated stem cell transplant | | Study to determine the most promising postgrafting immunosuppression for prevention of acute GVHD after unrelated donor G-CSF mobilized peripheral blood monuclear stem cell transplantation | | Open to Enrollment |
| | AML >55, Related sibling donors (MRD) | | Nonmyeloablative Allogeneic Peripheral Blood Stem Cell Transplantation from HLA Matched Related Donors for Treatment of Older Patients with De Novo or Secondary Acute Myeloid Leukemia in First Complete Remission | | Open to Enrollment |
| | Patients with low or falling donor T-cell chimerism s/p NMSCT | | Pentostatin and donor lymphocyte infusion for low donor t-cell chimerism after hematopoietic cell transplantation using nonmyeloablative conditioning - a mulit -center trial | | Open to Enrollment |
| | Patients with hematologic malignancies, Allogeneic Bone marrow transplant from HLA-idential sibling donor, single antigen mismatched related or unrelated donor, marrow/PBSC or cord blood available for marrow donation | | Rapamyucin for Immunosuppression and B cell Modulation post stem cell transplant for acute lymphoblastic leukemia | | Open to Enrollment |
| | Patients with hematologic malignancies | | Study comparing meiloablative to nonmyeloablative transplant conditioning in patients with myuelodyspastic syndrome or acute myelogenous leukemia | | Open to Enrollment |
| | Patients with hematologic malignaicies (related donor), decreased risk of rejection, no BMT within 6-8 months | | Comparison of nonmyeloablative conditioning with TBI versus Fludarabine/TBI for HLA-matched related hematopoietic cell transplantation | | Open to Enrollment |
| | Pulmonary Hypertension, Myelofibrosis, Bone Marrow, Scarring, Flolan | | Reversible Secondary Myelofibrosis or Clonal Myeloproliferative Disorder, IRB 17806 | | Open to Enrollment |
| | HLA matched related hematopoetic stem cell transplantation, increased risk of rejection, BMT within 6 months | | Study of nonmyeloablative conditioning with TBI or fludarabine/TBI | | Open to Enrollment |
| | Retrospective Clinical Database | | International Blood and Marrow Transplant Registry and Autologous Bone Marrow Transplant Registry - Development of outcomes databases | | Open to Enrollment |
| | Campath, allogeneic transplants with mis-matched related and unrelated donors, RP93 | | Campath® [Alemtuzumab] Dose Escalation, Low-Dose TBI and Fludarabine Followed by HLA Class I Mismatched Donor Stem Cell Transplantation for Patients with Hematologic Malignancies – A Multi-Center Trial | | Open to Enrollment |
| | Retrospective Clinical Database, RP126 | | Assessment of the Correlation between Pre-transplant Comorbidities and Post-Transplant Outcomes Using the Hematopoietic cell Transplantation-Specific Comorbidity Index (HCT-CI): A Multi-Center Trial | | Open |
| | Paroxysmal Nocturnal Hemoglobinuria, Hematopoietic Stem Cell, Prion Protein | | Role of Prion Protein in Human Hematopoietic Stem Cells | | Open to Enrollment |
| | Resistant lymphoma requiring auto/allo | | Study of autologous stem cell transplantation followed by non-myeloablative allogeneic stem cell transplantation for patients with relapsed or refractory lymphoma | | Closed to Enrollment |
Physicians
